METHOTREXATE
NDC 46708-712, methotrexate, injection, solution, from Alembic Pharmaceuticals Limited.
- Product NDC
- 46708-712
- Status
- Listed
- Labeler
- Alembic Pharmaceuticals Limited
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAMUSCULAR, INTRATHECAL, INTRAVENOUS, SUBCUTANEOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA220225
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/46708-712 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- METHOTREXATE SODIUM25 mg/mL
Pharmacologic classes
Folate Analog Metabolic Inhibitor [EPC]; Folic Acid Metabolism Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 46708-712-01 | 46708071201 | 1 VIAL, SINGLE-DOSE in 1 CARTON (46708-712-01) / 40 mL in 1 VIAL, SINGLE-DOSE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/e98b2abd-8068-482e-9ce3-1ab262f0838e
Use it
Look up 46708-712 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/46708-712 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 46708-712. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.